Attached files

file filename
10-Q - FORM 10-Q - PharMerica CORPd10q.htm
EX-31.1 - SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER - PharMerica CORPdex311.htm
EX-32.2 - SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER - PharMerica CORPdex322.htm
EX-10.44 - SUMMARY OF 2011 LONG-TERM INCENTIVE PROGRAM - PharMerica CORPdex1044.htm
EX-10.41 - CREDIT AGREEMENT - PharMerica CORPdex1041.htm
EX-10.42 - GUARANTEE AND COLLATERAL AGREEMENT - PharMerica CORPdex1042.htm
EX-10.43 - SUMMARY OF 2011 CEO SHORT-TERM INCENTIVE PROGRAM - PharMerica CORPdex1043.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER - PharMerica CORPdex312.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PharMerica Corporation (the “Corporation”) on Form 10-Q for the quarter ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Gregory S. Weishar, Chief Executive Officer and Director of the Corporation, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.

/s/    Gregory S. Weishar        

Gregory S. Weishar

Chief Executive Officer and Director

May 4, 2011